Carcinomas pavimentocelulares supraglóticos em estadios iniciais: Experiência de 10 anos do IPOLFG
DOI:
https://doi.org/10.34631/sporl.856Palavras-chave:
carcinomas pavimentocelulares supraglóticos, estadios iniciais, T1/T2N0, tratamento, sobrevidaResumo
Objetivos: Analisar o impacto do tratamento instituído nos resultados oncológicos de doentes com carcinomas pavimentocelulares supraglóticos T1/T2N0 (CPCST1/T2N0).
Desenho: Estudo retrospetivo.
Materiais e métodos: Revisão dos processos clínicos de doentes diagnosticados com CPCST1/T2N0 no Serviço de Otorrinolaringologia do IPOLFG entre 01-01-2005 e 31-12- 2014. Foram incluídos os doentes submetidos a tratamento com laringectomia parcial ou radioterapia definitiva (RTd) e foram excluídos aqueles com tumores síncronos da cabeça e pescoço ou antecedentes de CPC da laringe.
Para comparação dos resultados oncológicos, foram excluídos os doentes submetidos a cirurgia com tratamento adjuvante. Foram formados dois grupos de estudo: grupo cirúrgico e grupo RTd.
Resultados: O grupo cirúrgico apresentou uma sobrevida total mais elevada, mas uma sobrevida livre de doença mais baixa relativamente ao grupo RTd.
Conclusões: Comparando o grupo cirúrgico com o grupo RTd, não se verificou diferença estatisticamente significativa em termos de sobrevida.
Referências
Pfister DG, Spencer S, Adelstein D, Adkins D. et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Head and Neck Cancers- NCCN Evidence Blocks version 1.2020. National Comprehensive Cancer Network, Inc. [Internet]. 2020 Mar. Avaliable from:https://www.nccn.org: https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf
Amin MB, Edge S, Brookland R, Greene F, Brookland RK. et al. AJCC Cancer Staging Manual 8th Ed. Chicago: Springer. 2017. Available from: https://www.springer.com/gp/book/9783319406176
Pfister DG, Spencer S, Adelstein D, Adkins D. et al. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Head and Neck Cancers- NCCN Evidence Blocks version 1.2020. National Comprehensive Cancer Network, Inc. [Internet]. 2020 Mar. Avaliable from:https://www.nccn.org: https://www.nccn.org/professionals/physician_gls/pdf/head-and-neck.pdf
Sessions DG, Lenox J, Spector GJ. Supraglottic Laryngeal Cancer: Analysis of Treatment Results. Laryngoscope. 2005 Aug;115(8):1402-10. doi: 10.1097/01.MLG.0000166896.67924.B7.
Jones AS, Fish B, Fenton JE, Husband DJ. The treatment of early laryngeal cancers (T1-T2
N0): Surgery or Irradiation? Head Neck. 2004 Feb;26(2):127-35. doi: 10.1002/hed.10361.
Arshad H, Jayaprakash V, Gupta V, Cohan DM. et al. Survival Differences between Organ Preservation Surgery and Definitive Radiotherapy in Early Supraglottic Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2014 Feb; 150(2):237-244. doi: 10.1177/0194599813512783.
Spriano G, Antognoni P, Piantanida R, Varinelli D. et al. Conservative Management of T1-T2N0 Supraglottic Cancer: A Retrospective Study. Am J Otolaryngol. 1997 Sep-Oct;18(5):299-305. doi:10.1016/s0196-0709(97)90023-5.
Patel KB, Nichols AC, Fung K, Yoo J, MacNeil D. Treatment of Early Stage Supraglottic Squamous Cell Carcinoma: Meta-analysis comparing Primary Surgery versus Primary Radiotherapy. J Otolaryngo Head and Neck Surg. 2018 Mar; 47(19):1-8. doi: 10.1186/s40463-018-0262-2
Cabanillas R, Rodrigo JP, Llorente JL, Suárez V. et al. Functional Outcomes of Transoral Laser Surgery of Supraglottic Carcinoma Compared with a Transcervical Approach. Head Neck. 2004 Aug;26(8):653-659. doi:10.1002/hed.20063
Peretti G, Piazza C, Cattaneo A, Benedetto L. et al. Comparison of Functional Outcomes After Endoscopic versus Open-Neck Supraglottic Laryngectomies. Ann Otol Rhinol Laryngol. 2006 Nov; 115(11):827-32. doi:10.1177/000348940611501106.
Cagli S, Yuce I, Yigitbasi OG, Guney E. Is Routine Bilateral Neck Dissection Absolutely Necessary in the Management of N0 Neck in Patients with Supraglottic Carcinoma?. Eur Arch Otorhinolaryngol. 2007 Dec; 264(12):1453-7. doi: 10.1007/s00405-007-0384-z.
Redaelli de Zinis LO, Nicolai P, Tomenzoli D, Ghizzardi D. et al. The Distribution of Lymph Node Metastases in Supraglottic Squamous Cell Carcinoma: Therapeutic implications. Head Neck. 2002 Oct; 24(10):913-20. doi: 10.1002/hed.10152.
Deganello A, Gitti G, Meccariello G, Parrinello G, et al. Effectiveness and Pitfalls of Elective Neck Dissection in N0 Laryngeal Cancer. Acta Otorhinolaryngol Ital. 2011 Aug; 31:216-221. Available from: https://www.actaitalica.it/issues/2011/4-11/03%20Deganello.pdf
Cummings CW. Incidence of Nodal Metastases in T2 Supraglottic Carcinoma. Arch Otolayngol. 1974 April; 99(4):268-9. doi:10.1001/archotol.1974.00780030278008.
Langroudi MM, Amirzargar B, Amali A, Sadeghi M. et al. Rate of Occult Cervical Lymph Node Involvement in Supraglottic Squamous Cell Carcinoma. Iran J Otorhinolaryngol. 2017 May; 29(3):133-136. Avaliable from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5448027/pdf/ijo-29-133.pdf
Zhang Y, Xu S, Liu W, Xang K, et al. Rational choice of neck dissection in clinically N0 patients with supraglottic cancer. Head Neck. 2020 Mar;42(3):365-373. doi: 10.1002/hed.26014
Petrovic Z, Arsovic N, Trivic A. Selective neck dissection for no Neck Supraglottic Carcinoma. International Congress Series. 2003 Oct;1240:853-858. doi:10.1016/s0531-5131(03)00715-5.
Shah JP, Tollefsen HR. Epidermoid Carcinoma of the Supraglottic Larynx - Role of Neck Dissection in Initial Surgical Treatment. Am J Surg. 1974 Oct; 128(4):494-9. doi:10.1016/0002-9610(74)90262-1.
Lutz CK, Johnson JT, Wagner RL, Myers EN. Supraglottic Carcinoma: Patterns of Recurrence. Ann Otol Rhinol Laryngol. 1990 Jan; 99(1):12-7. doi: 10.1177/000348949009900103
Shi Y, Zhou L, Tao L, Zhang M. et al. Management of the N0 neck in Patients with Laryngeal Squamous Cell Carcinoma. Acta Otolaryngol. 2019 Oct; 139(10):908-912. doi: 10.1080/00016489.2019.1641219
Ambrosch P, Gonzalez-Donate M, Fazel A, Schmalz C. et al. Transoral Laser Microsurgery for Supraglottic Cancer. Front Oncol. 2018 May; 8: 158. doi:10.3389/fonc.2018.00158.
Canis M, Martin A, Ihler F, Wolff HA. et al. Results of Transoral Laser Microsurgery for Supraglottic Carcinoma in 277 patients. Eur Arch Otorhinolaryngol. 2013 Aug; 270(8):2315-26. doi:10.1007/s00405-012-2327-6.
Mendenhall WM, Parsons JT, Mancuso AA, Stringer SP. et al. Radiotherapy for squamous cell carcinoma of the supraglottic larynx: an alternative to surgery. Head Neck. 1996 Jan-Feb; 18(1):24-35. doi:10.1002/(SICI)1097-0347(199601/02)18:1<24::AID-HED4>3.0.CO;2-0.
Downloads
Publicado
Como Citar
Edição
Secção
Licença
Direitos de Autor (c) 2021 Revista Portuguesa de Otorrinolaringologia e Cirurgia de Cabeça e Pescoço
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição-NãoComercial-SemDerivações 4.0.
